We are live on ! Find out more
STML

Stemline Therapeutics, Inc.
STML

Delisted

STML was delisted on the 9th of June, 2020.

Back to rankings

56 hedge funds and large institutions have $184M invested in Stemline Therapeutics, Inc. in 2013 Q2 according to their latest regulatory filings, with 56 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
56
Holders Change
+56
Holders Change %
–
% of All Funds
1.83%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
56
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$786K +$525K +32,981 New
Morgan Stanley
27
Morgan Stanley
New York
$771K +$515K +32,313 New
RFC
28
Russell Frank Company
Washington
$688K +$459K +28,850 New
BIM
29
BlackRock Investment Management
Delaware
$568K +$379K +23,828 New
SIM
30
Spark Investment Management
New York
$487K +$328K +20,600 New
ARTA
31
A.R.T. Advisors
New York
$481K +$321K +20,184 New
TAM
32
Tocqueville Asset Management
New York
$434K +$290K +18,200 New
TD Asset Management
33
TD Asset Management
Ontario, Canada
$417K +$279K +17,500 New
EIM
34
Essex Investment Management
Massachusetts
$410K +$274K +17,217 New
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$380K +$254K +15,941 New
Charles Schwab
36
Charles Schwab
California
$326K +$207K +13,000 New
TA
37
Teachers Advisors
New York
$286K +$191K +12,012 New
Bank of America
38
Bank of America
North Carolina
$285K +$190K +11,949 New
Millennium Management
39
Millennium Management
New York
$207K +$139K +8,700 New
MLICM
40
Metropolitan Life Insurance Company (MetLife)
New York
$190K +$127K +7,976 New
Manulife (Manufacturers Life Insurance)
41
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$169K +$113K +7,100 New
AllianceBernstein
42
AllianceBernstein
Tennessee
$142K +$94.8K +5,951 New
Deutsche Bank
43
Deutsche Bank
Germany
$132K +$88.5K +5,556 New
SO
44
STRS Ohio
Ohio
$103K +$68.5K +4,300 New
BA
45
BlackRock Advisors
Delaware
$99K +$65.9K +4,138 New
NFA
46
Nationwide Fund Advisors
Ohio
$70K +$46.6K +2,929 New
MP
47
Manifold Partners
California
$46K +$31.1K +1,950 New
BJ
48
BlackRock Japan
Japan
$35K +$23.6K +1,481 New
SGAM
49
Smith Group Asset Management
Texas
$33K +$22.4K +1,404 New
Ameriprise
50
Ameriprise
Minnesota
$14K +$9.08K +570 New
1
2
3

STML Hedge Fund Activity: Q2 2013 in Review

56 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Stemline Therapeutics, Inc. (STML) for Q2 2013, worth a combined $184M.

Buyers outnumbered sellers: 56 funds opened new STML positions and 0 closed out — a net gain of 56 holders — while 0 added to existing stakes and 0 trimmed.

  • 56 institutional investors held Stemline Therapeutics, Inc. (STML) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $184M of Stemline Therapeutics, Inc. stock for Q2 2013.
  • 56 funds opened new Stemline Therapeutics, Inc. positions in Q2 2013 and 0 closed out, a net change of +56 holders.

Based on aggregated 13F filings for Q2 2013.